LMNA Reduced Acquired Resistance to Erlotinib in NSCLC by Reversing the Epithelial–Mesenchymal Transition via the FGFR/MAPK/c-fos Signaling Pathway
Chunsheng Hu(Chongqing University), Yan Tang(Chongqing University of Arts and Sciences)
Cited by 19
Related Papers
Lentivirus‑mediated silencing of CNTN1 enhances gefitinib sensitivity by reversing epithelial‑mesenchymal transition in lung adenocarcinoma A549 cells
|Oncology Letters|2021|4
CTBP2 contributes to cisplatin resistance in lung adenocarcinoma by inhibiting generation of reactive oxygen species
|Translational Cancer Research|2024|1